BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10940684)

  • 1. Somatostatin receptors.
    Benali N; Ferjoux G; Puente E; Buscail L; Susini C
    Digestion; 2000; 62 Suppl 1():27-32. PubMed ID: 10940684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular signaling of somatostatin receptors.
    Lahlou H; Guillermet J; Hortala M; Vernejoul F; Pyronnet S; Bousquet C; Susini C
    Ann N Y Acad Sci; 2004 Apr; 1014():121-31. PubMed ID: 15153426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New medical treatments in pituitary adenomas].
    Drutel A; Caron P; Archambeaud F
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction of somatostatin receptors negatively controlling cell proliferation.
    Ferjoux G; Bousquet C; Cordelier P; Benali N; Lopez F; Rochaix P; Buscail L; Susini C
    J Physiol Paris; 2000; 94(3-4):205-10. PubMed ID: 11087998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.
    Ben-Shlomo A; Pichurin O; Barshop NJ; Wawrowsky KA; Taylor J; Culler MD; Chesnokova V; Liu NA; Melmed S
    Mol Endocrinol; 2007 Oct; 21(10):2565-78. PubMed ID: 17609435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the somatostatin receptor subtypes (sst) mediating the divergent, stimulatory/inhibitory actions of somatostatin on growth hormone secretion.
    Luque RM; Durán-Prado M; García-Navarro S; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    Endocrinology; 2006 Jun; 147(6):2902-8. PubMed ID: 16543371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation.
    Spary EJ; Maqbool A; Batten TF
    J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects.
    Park S; Kamegai J; Kineman RD
    Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels.
    Reubi JC; Schaer JC; Laissue JA; Waser B
    Metabolism; 1996 Aug; 45(8 Suppl 1):39-41. PubMed ID: 8769377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands.
    Reubi JC; Waser B; Schaer JC; Laissue JA
    Eur J Nucl Med; 2001 Jul; 28(7):836-46. PubMed ID: 11504080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor subtypes sst1, sst2, sst3 and sst5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: comparison of mRNA analysis with receptor autoradiography.
    Schaer JC; Waser B; Mengod G; Reubi JC
    Int J Cancer; 1997 Mar; 70(5):530-7. PubMed ID: 9052751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumours of the gastrointestinal tract. Somatostatin receptors as tools for diagnosis and therapy: molecular aspects.
    Guillermet-Guibert J; Lahlou H; Pyronnet S; Bousquet C; Susini C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):535-51. PubMed ID: 16183526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum.
    Zaki M; Harrington L; McCuen R; Coy DH; Arimura A; Schubert ML
    Gastroenterology; 1996 Oct; 111(4):919-24. PubMed ID: 8831586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptors and regulation of cell proliferation.
    Bousquet C; Guillermet J; Vernejoul F; Lahlou H; Buscail L; Susini C
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S2-7. PubMed ID: 15077905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor expression and biological functions in endocrine pancreatic cells: review based on a doctoral thesis.
    Ludvigsen E
    Ups J Med Sci; 2007; 112(1):1-20. PubMed ID: 17578804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
    Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.